NeuSoft(SH:600718) Zheng Quan Shi Bao Wang·2025-08-26 06:07Group 1 - Neusoft Group's subsidiary, Neusoft Medical, has received approval from the National Medical Products Administration (NMPA) for its NeuViz P10 photon counting CT, marking it as China's first and the world's first 8cm wide photon counting CT, showcasing a leap from "catching up" to "leading" in next-generation CT technology [1] - The NeuViz P10 utilizes a cadmium zinc telluride (CZT) photon counting detector, revolutionizing traditional CT imaging principles by directly capturing and reading individual X-ray photon information, resulting in unprecedented ultra-high definition, ultra-low dose, and multi-energy imaging breakthroughs [1] - Neusoft Medical has partnered with top-tier hospitals for in-depth clinical research to explore the application potential of NeuViz P10 in complex diseases, accelerating its clinical value transformation [2] Group 2 - Neusoft Group has demonstrated that Chinese manufacturers are capable of not only catching up but also potentially leading in high-end medical equipment, which is crucial for the stability of supply and technological iteration in the context of complex international environments [2] - The success of NeuViz P10 aligns with national requirements for self-controllable high-end medical equipment, contributing to the public health system and national health security [2] - Neusoft Group is actively pursuing a strategic transformation aimed at enhancing operational performance, focusing on AI and big data innovations to create intelligent, data-driven, and service-oriented solutions [3] Group 3 - The company is leveraging new opportunities in AI and data value realization, leading to explosive growth in new product launches and order fulfillment [3] - Neusoft Group positions itself as a leader and enabler in medical health technology and business innovation, utilizing intelligent strategies to unlock new possibilities in the medical sector [3]